Harbour Investments »

Adial Pharmaceuticals shares owned by Harbour Investments

Quarter-by-quarter ownership of Adial Pharmaceuticals (ADIL) shares owned by Harbour Investments from 13F filings

Historical chart of Harbour Investments investment in Adial Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Adial Pharmaceuticals held by Harbour Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adial Pharmaceuticals by Harbour Investments

Quarter filed Position value Share count Share price at filing
2025-12-31 $21 99 0.22

More positions owned by Harbour Investments

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exchng Traded Fd Vi Smith Unconstrai (UCON)
First Tr Exchng Traded Fd Vi Ft Vest Laddered (BUFR)
Ishares Tr Core S&p Mcp Etf (IJH)
Apple (AAPL)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Series Trust State Street Spd (SPYM)
Vanguard World Inf Tech Etf (VGT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
NVIDIA Corporation (NVDA)

View all positions for Harbour Investments

Top funds holding Adial Pharmaceuticals

Vanguard Group
Geode Capital Management
Citadel Advisors
Jane Street
Northern Trust
Virtu Financial
XTX Topco
Manchester Capital Management
BlackRock
Intl Fcstone
Two Sigma Securities
Susquehanna International
Private Management Group
UBS Group
Tower Research Capital

View all funds holding Adial Pharmaceuticals